SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlbion. Dev Vct Regulatory News (AADV)

  • This share is currently suspended. It was suspended at a price of 85.00
  • There is currently no data for AADV

Albion Development VCT PLC: Interim Management Statement

22 Apr 2020 17:30



Albion Development VCT PLC: Interim Management Statement

Albion Development VCT PLC

Interim Management StatementLEI Code 213800FDDMBD9QLHLB38

IntroductionI present Albion Development VCT PLC (the “Company”)’s interim management statement for the period from 1 January 2020 to 31 March 2020.

Impact of coronavirus (Covid-19) and Net asset valueThe Board has been monitoring the ongoing disruption caused by the coronavirus (Covid-19) pandemic and its current impact on portfolio companies. These are unprecedented times with major uncertainty as to the ongoing economic and societal impact of the coronavirus (Covid-19) pandemic, the extent of which is still unknown.

In light of this, the Company announces its unaudited net asset value (NAV) as at 31 March 2020 of £71.85 million or 77.66 pence per share (excluding treasury shares), which represents a decrease of 5.81 pence per share (7.0 per cent.) since 31 December 2019. This reflects reductions across the portfolio, which is carried at fair value, as a result of market conditions arising from the healthcare pandemic. The Board has reassessed the carrying values of all companies within the portfolio and has reduced those which are affected by the current situation. The portfolio is well diversified and has weightings in sectors that are less badly affected by coronavirus (Covid-19) and many companies within the portfolio are well suited to operating in a remote environment.

The Company will pay a dividend of 2.25 pence per share on 29 May 2020 to shareholders on the register on 11 May 2020. After accounting for the dividend the NAV will be 75.41 pence per share.

Fundraising and share issuesDuring the period from 1 January 2020 to 31 March 2020, the Company issued the following new Ordinary shares of nominal value 1 penny per share under the Albion VCTs Prospectus Top Up Offers 2019/20:

DateNumber of shares issuedIssue price per share (including costs of issue)Net proceeds £’000
31 January 20209,034,37784.8p to 85.7p7,549

Share buy-backs

Given the uncertainty on valuations caused by coronavirus (Covid-19) and its impact on financial markets in recent times, the Board agreed to suspend the Company’s buy back operation on 18 March 2020 until such time as the Company could provide an updated valuation as at 31 March 2020 of the portfolio and the Company’s NAV.

With this announcement of the NAV of the Company at 31 March 2020, the Board is pleased to announce the resumption of its share buy-back policy, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders. However, the level of share buybacks until the announcement of the Company’s interim results, expected during September 2020 shall be limited to £500,000.

It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit.

Portfolio

The following investments have been made during the period from 1 January 2020 to 31 March 2020:

New investment£000sActivity
Concirrus Limited575A software provider bringing real-time behavioural data analytics to the marine and transport insurance industries
Credit Kudos Limited287Challenger credit bureau helping lenders optimise and automate their affordability and risk assessments
Total new investments862 

Top ten holdings as at 31 March 2020:

InvestmentCarrying value£’000% of net asset valueActivity
Egress Software Technologies Limited 6,4479.0%Encrypted email & file transfer service provider
Proveca Limited4,6006.4%Reformulation of paediatric medicines
Quantexa Limited 3,0104.2%Network analytics platform to detect financial crime
Radnor House School (TopCo) Limited 2,5473.5%Independent school for children aged 5-18
Chonais River Hydro Limited 2,3393.3%Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands
The Street by Street Solar Programme Limited 2,3273.2%Owns and operates photovoltaic systems on domestic properties in the UK
Regenerco Renewable Energy Limited 1,8942.6%Generator of renewable energy from roof top solar installations
Mirada Medical Limited 1,5442.1%Developer of medical imaging software using Deep Learning
G.Network Communications Limited 1,4792.1%Ultra-fast fibre optic broadband provider in central London
Alto Prodotto Wind Limited1,2421.7%Owns and operates community scale wind energy projects on brownfield sites in the UK

Material events and transactions after the period end

There have been no further significant events or transactions between 1 April 2020 and 22 April 2020 that the Board is aware of which would have had a material impact on the financial position of the Company.

Further informationThe Company continues to offer a Dividend Reinvestment Scheme to existing shareholders. Details of this Scheme can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AADV.

Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website under www.albion.capital/funds/AADV.

Ben Larkin, Chairman

22 April 2020For further information please contact:Albion Capital Group LLP – Tel: 020 7601 1850


Date   Source Headline
29th Jun 201811:45 amGNWTotal Voting Rights and Capital
14th Jun 20183:49 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
7th Aug 20094:53 pmRNSDirector/PDMR Shareholding
7th Aug 20092:57 pmPRNNet Asset Value(s)
7th Aug 20092:51 pmRNSClosing of offer for shares of HRG
31st Mar 20095:09 pmRNSTotal Voting Rights
25th Mar 20093:25 pmRNSChange of Name
18th Mar 200911:11 amRNSFSA viewing facility
27th Feb 20092:51 pmRNSTotal Voting Rights
30th Jan 20094:08 pmRNSTotal Voting Rights
23rd Jan 200911:55 amRNSChange of Inv Manager and Proposed Change o
9th Jan 20095:38 pmRNSDirector/PDMR Shareholding
31st Dec 200811:03 amRNSTotal Voting Rights
30th Dec 200810:30 amRNSIssue of Equity
10th Dec 20083:38 pmRNSTransaction in Own Shares
9th Dec 20084:47 pmRNSDoc re. Dividend
4th Dec 200810:16 amRNSDividend Declaration
28th Nov 20085:46 pmRNSTotal Voting Rights
12th Nov 20085:46 pmRNSInterim Management Statement
31st Oct 20084:35 pmRNSTotal Voting Rights
14th Oct 20084:14 pmRNSTransaction in Own Shares
13th Oct 20084:39 pmRNSTransaction in Own Shares
7th Oct 20084:44 pmRNSDirector/PDMR Shareholding
3rd Oct 20083:07 pmRNSIssue of Equity
30th Sep 20085:05 pmRNSTotal Voting Rights
25th Sep 20082:43 pmRNSTransaction in Own Shares
16th Sep 20085:25 pmRNSTransaction in Own Shares
11th Sep 20085:27 pmRNSTransaction in Own Shares
9th Sep 20089:52 amRNSDoc re. FSA viewing facility
3rd Sep 20084:32 pmRNSTransaction in Own Shares
29th Aug 20085:02 pmRNSTotal Voting Rights
27th Aug 20086:28 pmRNSInterim Results
31st Jul 20084:43 pmRNSTotal Voting Rights
30th Jun 20085:58 pmRNSTotal Voting Rights
27th Jun 20084:26 pmRNSTransaction in Own Shares
20th Jun 20082:58 pmRNSTransaction in Own Shares
12th Jun 20083:00 pmRNSDirector/PDMR Shareholding
12th Jun 20082:31 pmRNSTransaction in Own Shares
10th Jun 20084:03 pmRNSDirector/PDMR Shareholding-Am
10th Jun 20083:32 pmRNSDirector/PDMR Shareholding
3rd Jun 20082:22 pmRNSDirector/PDMR Shareholding
2nd Jun 200811:45 amRNSDoc re. Sale of Investment -
30th May 20084:41 pmRNSTotal Voting Rights
19th May 200812:09 pmRNSInterim Management Statement
30th Apr 20085:00 pmRNSTotal Voting Rights
30th Apr 20081:14 pmRNSDoc re. Close Period
22nd Apr 20086:10 pmRNSAnnual Information Update
16th Apr 20089:05 amRNSFSA viewing facility
7th Apr 20085:28 pmRNSDoc re. Close Period
7th Apr 20085:22 pmRNSFinal Results - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.